Epilepsy Market Research Reports & Industry Analysis
Epilepsy Industry Research & Market Reports
-
Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More
-
Connected Care in North America 3rd Edition
... and remote patient monitoring (RPM) markets in thisregion. This strategic research report from Berg Insight providesyou with 150 pages of unique business intelligence including 5-yearindustry forecasts and expert commentary on which to base yourbusiness decisions. Read More
-
Epilepsy Drugs
... at a CAGR of 3.8% over the analysis period 2023-2030. First Generation Epilepsy Drugs, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$1.6 Billion by the ... Read More
-
South & Central America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The South & Central America epilepsy market was valued at US$ 593.56 million ... Read More
-
North America Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The North America epilepsy market was valued at US$ 2,577.10 million in 2022 and is ... Read More
-
Europe Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Europe epilepsy market was valued at US$ 1,940.58 million in 2022 and is expected to ... Read More
-
Asia Pacific Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Asia Pacific epilepsy market was valued at US$ 2,200.92 million in 2022 and is ... Read More
-
Middle East & Africa Epilepsy Market Forecast to 2030 - Regional Analysis - by Type (Progressive Myoclonic Epilepsy, Reflex Epilepsy, Generalized Epilepsy, and Other), Route of Administration (Oral, Parenteral, and Others), Treatment Type (First Generation Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others)
... Drugs, Second Generation Drugs, and Third Generation Drugs), Age Group (Adult and Children), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Others) The Middle East & Africa epilepsy market was valued at US$ 456.34 million ... Read More
-
Bioelectric Medicine Market Research Report Information by Type (Implantable Electroceutical Devices and Non-invasive Electroceutical Devices), by Product (Implantable Cardioverter Defibrillators, Cardiac Pacemakers, Cochlear Implants, Spinal Cord Stimulators, Deep Brain Stimulators, Transcutaneous Electrical Nerve Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators, And Others), By Application (Arrhythmia, Pain Management, Sensorineural Hearing Loss, Epilepsy, And Others), By End User (Hospitals & Clinics, ASCs, and Others), By Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2030
... Substance Abuse Disorder, Schizophrenia, and Other Mental Disorder] and Behavioral Disorder [Attention Deficit Hyperactivity Disorder (ADHD), Emotional Behavioral Disorder, Oppositional Defiant Disorder, Obsessive Compulsive Disorder (OCD), and Other Behavioral Disorder]), by Age Group (Children & ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2034
... Syndrome in the US were ~50,090. In 2023, the total diagnosed prevalent cases of Early Myoclonic Encephalopathy in Japan were around 20, where as the diagnosed prevalent cases of Epileptic Encephalopathy with continuous spike-and-wave during ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034
... which is expected to grow at a CAGR of ~40% during the forecast period (2020-2034). Among EU4 and the UK, Germany will capture the maximum revenue share, followed by Italy in 2034. In the 7MM, ... Read More
-
Global Pediatric Home Healthcare Market Size Study, by Services (Skilled Nursing Services, Personal Care Assistance, Rehabilitation Therapy Services), by Application (Cancer, Respiratory Disease, Cardiovascular Disease, Physical Disabilities, Others), and Regional Forecasts 2022-2032
... Healthcare Market is valued at USD 39.69 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.7% over the forecast period 2024-2032. Pediatric home healthcare is a comprehensive, ... Read More
-
Global Brain Imaging Devices Market Size study, by Product (Devices, Accessories) by Application (Stroke, Brain Tumor, Traumatic brain injury (TBI), Epilepsy, Sleep Apnea, Headache, Structural anomalies, Other Applications) by Modality (Fixed, Portable, W
... Use (Hospitals, Diagnostic Imaging Centers, Ambulatory Surgery Centers, Other End-users) and Regional Forecasts 2022-2032 Global Brain Imaging Devices Market is valued approximately USD 5.26 billion in 2023 and is anticipated to grow with a growth ... Read More
-
Deep Brain Stimulation Devices
... reach US$2.9 Billion by 2030, growing at a CAGR of 8.4% over the analysis period 2023-2030. Dual-Channel Deep Brain Stimulation Devices, one of the segments analyzed in the report, is expected to record a 8.0% ... Read More
-
United States Generic Drugs Market Report By Therapeutic Area (Epilepsy, Cancers, Heart Disease, Mental Health, Diabetes, Allergies & Asthama, Chronic Obstructive Pulmonary Diesase, Alzheimer's Disease, HIV/AIDS, Crohn's colitis), Type (Branded Generics, Unbranded Generics), Drug Delivery (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, Medicare D), States and Company analysis 2024-2032
... (Oral, Dermal/Topical, Injectables, Inhalers), Age Group (Children (0-19 years), Young Adults (20-39 years), Adults (40-64 years), Seniors (Above 65 years)), Distribution Channel (Hospital Pharmacy, Specialty Pharmacy, Retail Pharmacy, Online Pharmacy), Payment Type (Cash, Commercial, Medicaid, ... Read More
-
Global Deep Brain Stimulation Market: Analysis By Product (Dual Channel and Single Channel), By Application (Parkinson’s Disease, Essential Tremor, Dystonia, Epilepsy and Others), By End Use (Hospitals, Neurology Clinics, Ambulatory Surgical Clinics and Research Centers), By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029
... By Region Size and Trends with Impact of COVID-19 and Forecast up to 2029 - Report Summary Report Metrics Details Years Considered 2019-2023 Base Year 2023 Forecast Period 2024-2029 Page Count 153 Units Referenced US ... Read More
-
Global Dravet Syndrome Treatment Market 2024-2028
... dravet syndrome treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Global Electroceutical Bioelectric Medicine Market 2024-2028
... electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Drug Resistant Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Drug Resistant Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Drug Resistant Epilepsy market report provides current ... Read More
-
KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE), historical and forecasted epidemiology as well as the KCNQ2 Developmental and Epileptic Encephalopathy (KCNQ2-DEE) market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Partial Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Partial Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Partial Epilepsy market report provides current treatment practices, emerging drugs, Partial ... Read More
-
Refractory Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Refractory Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Refractory Epilepsy market report provides current treatment practices, emerging drugs, Refractory ... Read More
-
Dravet Syndrome – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Dravet Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Dravet Syndrome market report provides current treatment practices, emerging drugs, Dravet ... Read More
-
Chronic Focal Epilepsy – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Chronic Focal Epilepsy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Chronic Focal Epilepsy market report provides current ... Read More
-
North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe).
... (US, Canada, Europe) It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures ... Read More
Research Assistance
